CareTrust REIT (CTRE) Stock Forecast & Price Target

CareTrust REIT is well positioned because it is deploying capital aggressively into healthcare real estate at a time when tenant credit concerns have stabilized and private-market valuations for skilled nursing facilities are improving. Its recent activity, including $710 million of new investments in 3Q26 and the $764 million LNT acquisition, should support FFO growth to $2.08/share in 2026 and $2.31/share in 2027, while the company’s platform expansion across U.S. and UK assets broadens its growth runway. Although leverage may rise toward ~1.8x net debt to EBITDA, the triple-net lease structure, accretive funding mix, and management’s ability to source proprietary deal flow make the outlook fundamentally constructive.

CareTrust REIT is viewed negatively because its earnings trajectory is highly exposed to a deteriorating reimbursement backdrop, especially Medicaid cuts, which could stall growth at its 2026 run-rate and pressure valuation multiples back toward the 7-year historical average of about 14.0x. The outlook is further clouded by re-emerging PACS-related headline risk and an unresolved DOJ investigation, both of which could undermine investor confidence and delay a cleaner fundamental re-rating. In addition, a more competitive transaction market and uncertainty around labor, regulation, and cost of capital could make accretive capital deployment harder, limiting the company’s ability to sustain healthy earnings growth.